| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparison of anxiety symptoms and correlates of anxiety in people with progressive and relapsing-remitting multiple sclerosis
|
Knowles, Lindsey M.
|
|
|
63 |
C |
p.
|
artikel
|
| 2 |
A cross-sectional analysis of persistence to disease-modifying therapies in treatment naïve and experienced patients with relapsing multiple sclerosis at a health-system specialty pharmacy
|
Kozlicki, Miranda Z.
|
|
|
63 |
C |
p.
|
artikel
|
| 3 |
Alemtuzumab induced hemodynamic change in relapsing multiple sclerosis occurs independent of corticosteroid premedication – a retrospective multicentre study
|
Di Pauli, Franziska
|
|
|
63 |
C |
p.
|
artikel
|
| 4 |
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis
|
Ponzano, Marta
|
|
|
63 |
C |
p.
|
artikel
|
| 5 |
An epidemiological analysis of multiple sclerosis patients hospitalized in the United States
|
Ramphul, Kamleshun
|
|
|
63 |
C |
p.
|
artikel
|
| 6 |
Antibody response to SARS-CoV-2 vaccination following typical and three-dose dosing schedules in multiple sclerosis patients treated with disease modifying therapies
|
Wallach, Asya I.
|
|
|
63 |
C |
p.
|
artikel
|
| 7 |
A quarter-century report on neuromyelitis optica spectrum disorder in Thailand: A single-center tertiary care cohort
|
Tisavipat, Nanthaya
|
|
|
63 |
C |
p.
|
artikel
|
| 8 |
Associations between diet quality and depression, anxiety, and fatigue in multiple sclerosis
|
Saul, A
|
|
|
63 |
C |
p.
|
artikel
|
| 9 |
Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL
|
Gawde, Saurabh
|
|
|
63 |
C |
p.
|
artikel
|
| 10 |
Blood-brain barrier permeability changes in the first year after alemtuzumab treatment predict 2-year outcomes in relapsing-remitting multiple sclerosis
|
Knudsen, Maria Højberg
|
|
|
63 |
C |
p.
|
artikel
|
| 11 |
Brain-derived neurotrophic factor and neurofilament light chain in cerebrospinal fluid are inversely correlated with cognition in Multiple Sclerosis at the time of diagnosis
|
Yalachkov, Yavor
|
|
|
63 |
C |
p.
|
artikel
|
| 12 |
Burden of multiple sclerosis: impact on the patient, family and society
|
Sarhan, Abdallah A.
|
|
|
63 |
C |
p.
|
artikel
|
| 13 |
Cerebrospinal fluid amyloid precursor protein as a potential biomarker of fatigue in multiple sclerosis: A pilot study
|
Johansson, Kalle
|
|
|
63 |
C |
p.
|
artikel
|
| 14 |
Characterization of immune profile in an aging multiple sclerosis clinic population
|
Keegan, Andrew P.
|
|
|
63 |
C |
p.
|
artikel
|
| 15 |
Clinical outcomes of partial sensory root rhizotomy on patients with recurrence of multiple sclerosing trigeminal neuralgia after percutaneous balloon compression
|
Li, Yuanchao
|
|
|
63 |
C |
p.
|
artikel
|
| 16 |
COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders
|
Conway, Sarah E.
|
|
|
63 |
C |
p.
|
artikel
|
| 17 |
Defining milestones for the study of remyelination using the cuprizone mouse model: How early is early?
|
Palavra, Filipe
|
|
|
63 |
C |
p.
|
artikel
|
| 18 |
Delayed and recurrent dimethyl fumarate induced-lymphopenia in patients with multiple sclerosis
|
Borrelli, S.
|
|
|
63 |
C |
p.
|
artikel
|
| 19 |
Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies
|
Masanneck, Lars
|
|
|
63 |
C |
p.
|
artikel
|
| 20 |
Dimethyl fumarate is associated with lower rates of infection and lower infection-related healthcare costs when compared with ocrelizumab
|
Nicholas, Jacqueline A
|
|
|
63 |
C |
p.
|
artikel
|
| 21 |
Disease modifying therapy management of multiple sclerosis after stem cell therapies: A retrospective case series
|
Manzano, Giovanna S.
|
|
|
63 |
C |
p.
|
artikel
|
| 22 |
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
|
Brieva, Luis
|
|
|
63 |
C |
p.
|
artikel
|
| 23 |
Disproportional increase in psoriasis reports in association with B cell depleting therapies in patients with multiple sclerosis
|
Porwal, Mokshal H.
|
|
|
63 |
C |
p.
|
artikel
|
| 24 |
Do device-measured physical activity and sedentary behavior differ by depression symptom status in persons with multiple sclerosis?
|
Jones, C. Danielle
|
|
|
63 |
C |
p.
|
artikel
|
| 25 |
Effectiveness of acceptance and commitment therapy for improving quality of life and mood in individuals with multiple sclerosis: A systematic review and meta-analysis
|
Thompson, Bethany
|
|
|
63 |
C |
p.
|
artikel
|
| 26 |
Effects and safety of exergaming in persons with multiple sclerosis during corticosteroid treatment: a pilot study
|
Ozdogar, Asiye Tuba
|
|
|
63 |
C |
p.
|
artikel
|
| 27 |
Effects of disease-modifying treatments discontinuation in patients with relapsing-remitting multiple sclerosis: A 5 year prospective cohort study
|
Bawand, Rashed
|
|
|
63 |
C |
p.
|
artikel
|
| 28 |
Efficacy of Fluoxetine, Riluzole and Amiloride in treating neuropathic pain associated with secondary progressive multiple sclerosis. Pre-specified analysis of the MS-SMART double-blind randomised placebo-controlled trial
|
Foley, Peter
|
|
|
63 |
C |
p.
|
artikel
|
| 29 |
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)
|
Dobson, Ruth
|
|
|
63 |
C |
p.
|
artikel
|
| 30 |
Evaluation of adherence to treatment in patients with multiple sclerosis from Latin America
|
Alonso, Ricardo
|
|
|
63 |
C |
p.
|
artikel
|
| 31 |
Ex-Gaussian analysis of simple response time as a measure of information processing speed and the relationship with brain morphometry in multiple sclerosis
|
Mui, Michelle
|
|
|
63 |
C |
p.
|
artikel
|
| 32 |
Faster B-cell repletion after anti-CD20 infusion in Black patients compared to white patients with neurologic diseases
|
Saidenberg, Lucia
|
|
|
63 |
C |
p.
|
artikel
|
| 33 |
Fatigue and brain atrophy in Egyptian patients with relapsing remitting multiple sclerosis
|
Khedr, Eman M
|
|
|
63 |
C |
p.
|
artikel
|
| 34 |
Feedback from neurology residents and neuroimmunology fellows about the practical training in multiple sclerosis
|
Diogo Silva, Guilherme
|
|
|
63 |
C |
p.
|
artikel
|
| 35 |
Genetic biomarkers in multiple sclerosis: An umbrella review of meta-analyses of observational studies
|
Tempest, Adelaide
|
|
|
63 |
C |
p.
|
artikel
|
| 36 |
German guideline for diagnosis and treatment of multiple sclerosis – a survey focusing neurologists in daily practise
|
Heesen, C.
|
|
|
63 |
C |
p.
|
artikel
|
| 37 |
Global assessment of characteristics of multiple sclerosis registries; A systematic review
|
Ezabadi, Sajjad Ghane
|
|
|
63 |
C |
p.
|
artikel
|
| 38 |
Has the pandemic changed treatment strategy in multiple sclerosis?
|
Bsteh, Gabriel
|
|
|
63 |
C |
p.
|
artikel
|
| 39 |
Hiding in plain sight: The magnitude of unused disease modifying therapies in multiple sclerosis and strategies for reducing the economic burden of care
|
Okuda, Darin T.
|
|
|
63 |
C |
p.
|
artikel
|
| 40 |
HLA-genotyping by next-generation-sequencing reveals shared and unique HLA alleles in two patients with coexisting neuromyelitis optica spectrum disorder and thymectomized myasthenia gravis: Immunological implications for mutual aetiopathogenesis?
|
Vakrakou, Aigli
|
|
|
63 |
C |
p.
|
artikel
|
| 41 |
Home treatment against fatigue in multiple sclerosis by a personalized, bilateral whole-body somatosensory cortex stimulation
|
Tecchio, Franca
|
|
|
63 |
C |
p.
|
artikel
|
| 42 |
How important are COVID-19 vaccine responses in patients with MS on disease-modifying therapies?
|
Giovannoni, Gavin
|
|
|
63 |
C |
p.
|
artikel
|
| 43 |
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis
|
Zappulo, Emanuela
|
|
|
63 |
C |
p.
|
artikel
|
| 44 |
Impact of telehealth on health care in a multiple sclerosis outpatient clinic during the COVID-19 pandemic
|
Li, Vivien
|
|
|
63 |
C |
p.
|
artikel
|
| 45 |
Implementing education: Personal communication with a healthcare professional is a critical step to address vaccine hesitancy for people with multiple sclerosis
|
Panisset, M.G.
|
|
|
63 |
C |
p.
|
artikel
|
| 46 |
Incomplete reporting of patient-reported outcomes in multiple sclerosis: A meta-epidemiological study of randomized controlled trials
|
Khan, Taimoor
|
|
|
63 |
C |
p.
|
artikel
|
| 47 |
Is EB virus the cause of MS? – A way forward
|
Thompson, Edward John
|
|
|
63 |
C |
p.
|
artikel
|
| 48 |
Isometric tests to evaluate upper and lower extremity functioning in people with multiple sclerosis: reliability and validity
|
Uygur, Mehmet
|
|
|
63 |
C |
p.
|
artikel
|
| 49 |
Is there a link between neuropathic pain and constipation in NMOSD and MOGAD? Results from an online patient survey and possible clinical implications
|
Lotan, Itay
|
|
|
63 |
C |
p.
|
artikel
|
| 50 |
Late onset neuromyelitis optica spectrum disorders (LONMOSD) from a nationwide Portuguese study: Anti-AQP4 positive, anti-MOG positive and seronegative subgroups
|
Santos, Ernestina
|
|
|
63 |
C |
p.
|
artikel
|
| 51 |
Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine
|
Brill, Livnat
|
|
|
63 |
C |
p.
|
artikel
|
| 52 |
miRNAs in multiple sclerosis: A clinical approach
|
MINUTTI-ZANELLA, Claudia
|
|
|
63 |
C |
p.
|
artikel
|
| 53 |
Moderate-to-vigorous physical activity is associated with processing speed, but not learning and memory, in cognitively impaired persons with multiple sclerosis
|
Motl, Robert W.
|
|
|
63 |
C |
p.
|
artikel
|
| 54 |
Motherhood choice in multiple sclerosis (MoMS) development and piloting of patient-reported outcome measures
|
Steinberg, Lea
|
|
|
63 |
C |
p.
|
artikel
|
| 55 |
Multiple sclerosis incidence: A systematic review of change over time by geographical region
|
Lane, Jo
|
|
|
63 |
C |
p.
|
artikel
|
| 56 |
Multiple sclerosis is one disease
|
Giovannoni, Gavin
|
|
|
63 |
C |
p.
|
artikel
|
| 57 |
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review
|
Abbadessa, Gianmarco
|
|
|
63 |
C |
p.
|
artikel
|
| 58 |
Plasma 24-hydroxycholesterol is associated with narrower common carotid artery and greater flow velocities in relapsing multiple sclerosis
|
Jakimovski, Dejan
|
|
|
63 |
C |
p.
|
artikel
|
| 59 |
Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, Italy
|
Orlandi, Riccardo
|
|
|
63 |
C |
p.
|
artikel
|
| 60 |
Prognosis of walking function in multiple sclerosis supported by gait pattern analysis
|
Zörner, Björn
|
|
|
63 |
C |
p.
|
artikel
|
| 61 |
Prognostic value of intrathecal IgM synthesis determined by various laboratory methods in patients with early multiple sclerosis - a prospective observational study
|
Revendova, Kamila
|
|
|
63 |
C |
p.
|
artikel
|
| 62 |
Quality of life in pediatric-onset multiple sclerosis: Different disease course, different impact, different measurement approach needed
|
Ow, Nikki
|
|
|
63 |
C |
p.
|
artikel
|
| 63 |
Quantification of upper limb dysfunction in the activities of the daily living in persons with multiple sclerosis
|
Pisa, Marco
|
|
|
63 |
C |
p.
|
artikel
|
| 64 |
Real-world study of relapsing-remitting multiple sclerosis patients treated with Teriflunomide in Nordic countries: Quality-Of-Life, efficacy, safety and adherence outcomes
|
Hestvik, Anne Lise K.
|
|
|
63 |
C |
p.
|
artikel
|
| 65 |
Relationship between apathy and cognitive dysfunctions in multiple sclerosis: A 4-year prospective longitudinal study
|
Raimo, Simona
|
|
|
63 |
C |
p.
|
artikel
|
| 66 |
Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders
|
Dinoto, Alessandro
|
|
|
63 |
C |
p.
|
artikel
|
| 67 |
SARS-CoV-2 infection in patients with neuroimmunological disorders in a tertiary referral centre from the north of Portugal
|
Moura, João
|
|
|
63 |
C |
p.
|
artikel
|
| 68 |
Short report: Real-life analysis of the occurrence of persistent, transient, and fluctuating positive titres of neutralizing anti-drug antibodies in multiple sclerosis patients treated with interferon beta
|
Oviedo Querejazu, Matilde
|
|
|
63 |
C |
p.
|
artikel
|
| 69 |
Sick leave and occupational burnout among nurses caring for patients with multiple sclerosis
|
Saposnik, Gustavo
|
|
|
63 |
C |
p.
|
artikel
|
| 70 |
The effect of cognitive performance on self-management behavior of multiple sclerosis patients
|
Efendi, Hüsnü
|
|
|
63 |
C |
p.
|
artikel
|
| 71 |
The effect of virtual reality-based therapy on fear of falling in multiple sclerosis: A systematic review and meta-analysis
|
Akkan, Hakan
|
|
|
63 |
C |
p.
|
artikel
|
| 72 |
The efficacy and safety of mycophenolate mofetil in Thai neuromyelitis optica spectrum disorder patients
|
Pathomrattanapiban, Charinya
|
|
|
63 |
C |
p.
|
artikel
|
| 73 |
The impact of COVID-19 on people with multiple sclerosis: A comparison of Italian and United States cohorts
|
Schwartz, Carolyn E.
|
|
|
63 |
C |
p.
|
artikel
|
| 74 |
The influence of COVID-19 pandemic lockdown on the physical activity of people with multiple sclerosis. The role of online training
|
Matysiak, Mariola
|
|
|
63 |
C |
p.
|
artikel
|
| 75 |
The influence of disease-modifying therapy on hidden disability burden in people with newly diagnosed relapsing-remitting multiple sclerosis
|
Glasmacher, Stella A
|
|
|
63 |
C |
p.
|
artikel
|
| 76 |
The innovative animal monitoring device for experimental autoimmune encephalomyelitis (“I AM D EAE”): A more detailed evaluation for improved results
|
Osorio-Querejeta, Iñaki
|
|
|
63 |
C |
p.
|
artikel
|
| 77 |
The metabolic potential of the paediatric-onset multiple sclerosis gut microbiome
|
Mirza, Ali I
|
|
|
63 |
C |
p.
|
artikel
|
| 78 |
The prevalence of internuclear ophthalmoparesis in a population-based cohort of individuals with multiple sclerosis
|
Hof, S.N.
|
|
|
63 |
C |
p.
|
artikel
|
| 79 |
The Sylvia Lawry Centre for Multiple Sclerosis Research (SLCMSR)––Critical review facing the 20 anniversary
|
Heesen, C
|
|
|
63 |
C |
p.
|
artikel
|
| 80 |
The true burden of heart failure among multiple sclerosis patients: Addressing potential publication bias
|
Shahid, Abia
|
|
|
63 |
C |
p.
|
artikel
|
| 81 |
Tixagevimab and Cilgavimab (Evusheld) boosts antibody levels to SARS-CoV-2 in patients with multiple sclerosis on b-cell depleters
|
Conte, William L.
|
|
|
63 |
C |
p.
|
artikel
|
| 82 |
Using MS induced pluripotent stem cells to investigate MS aetiology
|
Fortune, Alastair J
|
|
|
63 |
C |
p.
|
artikel
|
| 83 |
Validation of two new scales for the assessment of fatigue in Multiple Sclerosis: F-2-MS and FACIT-F
|
Delgado-Álvarez, Alfonso
|
|
|
63 |
C |
p.
|
artikel
|
| 84 |
Validity and reliability of the 10-item Connor-Davidson Resilience Scale (CD-RISC-10) in a sample of Spanish-speaking patients with Multiple Sclerosis
|
Broche-Pérez, Yunier
|
|
|
63 |
C |
p.
|
artikel
|
| 85 |
Validity and reliability of the 3-meter backward walk test in patients with multiple sclerosis
|
Katirci Kirmaci, Zekiye İpek
|
|
|
63 |
C |
p.
|
artikel
|
| 86 |
Validity and sensitivity of Canadian normative data for the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) battery
|
Berard, Jason A.
|
|
|
63 |
C |
p.
|
artikel
|
| 87 |
What would improve MS clinic services for cognition? – A stakeholder panel and survey exploration
|
Langdon, Dawn
|
|
|
63 |
C |
p.
|
artikel
|
Tijdschrift beschrijving